BioSpace News Archive

Award Recognizes the Nobel-Prize Winning Science Behind ONPATTRO and its Impact on Patients Living with the Polyneuropathy of Hereditary ATTR (hATTR) Amyloidosis

Pear Therapeutics, Inc. announced that the Galien Foundation has awarded the 2020 Prix Galien USA Award for Best Digital Health Product to Somryst™, the first FDA-authorized prescription digital therapeutic for patients with chronic insomnia.

Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced its financial results for the quarter ended September 30, 2020 and provided a corporate update.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, and George Mason University’s (Mason’s) National Center for Biodefense and Infectious Diseases (NCBID), today jointly announce completion of extensive laboratory testing supporting anti-SARS-CoV-2 activity of Brilacidin, a defensin-mimetic drug candidate, which is being developed as a potential COVID-19 treatment.

MagicMed Industries Inc. is pleased to announce that it has entered into a Research Contract and a Facilities Use Agreement with the University of Calgary.

A disposable syringe enables doctors to make use of the product and then dispose it off so that the risk of contamination is nullified and medical care is accelerated.

The cranial and facial implants market may garner substantial growth during the forecast period of 2020-2030.

The market for sinus therapeutic drugs or medication for managing sinusitis has made advances on the back of expanding understanding of the etiology of sinusitis, now more popularly known as rhinosinusitis.

Muse® by Interaxon Inc., a leading consumer neurotechnology and meditation company, appoints neuroscientist and digital medicine expert Walter Greenleaf as Chief Science Officer.

Protagonist Therapeutics, Inc. reported that on October 31, 2020, it issued an inducement award to Nora Boyer, the Company’s recently hired Vice President, Medical Affairs, in accordance with the terms of Ms. Boyer’s employment offer letter.